Delivery Order SPE2DB20D1100-SPE2DB24FA9Q2

Award Date 3/26/24
Potential Completion Date 3/27/24
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense agency. The contract is for the delivery of Gilenya 0.5 mg capsules, a specialty medication, with a ceiling value of $26,943.61 and a performance period through October 2023. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,271.58 firm-fixed-price delivery order is for the supply of Gilenya 0.5 mg capsules and has an ultimate completion date of May 11, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $15,661.20, is for the delivery of the drug Gilenya 0.5 mg capsules. The contract is a firm fixed-price, delivery order contract with an ultimate completion date of August 7, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $17,114.08 firm fixed price delivery order is for the supply of Gilenya 0.5 mg capsules. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract has an ultimate completion date of March 18, 2024 and is issued under Amerisourcebergen Drug Corp's indefinite...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Gilenya 0.5 mg capsules. The contract has a ceiling value of $41,555.95 and a term ending on June 11, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $45,359.88 firm-fixed-price contract is for the delivery of Gilenya 0.5 mg capsules, a prescription medication. The award has an ultimate completion date of August 13, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical for providing a comprehensive range of medical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,549.84, is for the delivery of Gilenya 0.5 mg capsules. The contract has an ultimate completion date of April 17, 2023 and is a firm fixed-price delivery order. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Gilenya 0.5 mg capsules. The contract has a ceiling value of $26,277.64 and was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 23, 2023. The contract is not designated with a set-aside. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,750.55 firm fixed-price delivery order is for the supply of Gilenya 0.5 mg capsules, with a completion date of September 20, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Gilenya 0.5 mg capsules to support medical supply needs. The $19,335.84 firm fixed-price contract was awarded on May 19, 2023 by the Defense Logistics Agency (DLA) Troop Support Medical with a completion date of May 22, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FA9Q2
    Delivery Order

This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Gilenya 0.5 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The fixed-price delivery order, valued at $20,129.07, has a completion date of March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor and is not operating under a set-aside designation.

In addition to this specific award, Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. Amerisourcebergen also has a separate $750,000 indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division to provide medical supplies and prescription medications.

Generated 6/25/24, 1:37 PM